Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors

In this new paper Generation of spatially resolved gene expression patterns in tumors from patients with ovarian cancer surviving more than 10 years allows the identification of novel predictive biomarkers and therapeutic targets for better patient management.

Previous post
From patterns to patients- Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment Next post
Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity